Overview
BiotechPhase 3DMTpsilocybin
Nonprofit conducting Phase 2 psilocybin trials for MDD. Open-source approach.
Visit WebsiteMadison, WI
5
Clinical Trials
2014
Founded
30
Employees
0
Open Roles
Open Positions
No open positions at this time
Research Areas
Clinical Pipeline(5)
Completed·Phase 1·DMT
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
5-methoxy-N,N-dimethyltryptamine succinate saltPharmacokinetics
Completed·Phase 1·psilocybin
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
PsilocybinQTc Interval
Terminated·N/A·psilocybin
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
No intervention will be administered as part of this study.Major Depressive Disorder
Completed·Phase 2·psilocybin
A Study of Psilocybin for Major Depressive Disorder (MDD)
PsilocybinDepressive Disorder, Major
Active, Not Recruiting·Phase 3·psilocybin
Psilocybin for Major Depressive Disorder (MDD)
Psilocybin 25 mgDepressive Disorder, Major